Memorial Sloan Kettering Radiation Oncology
@MSK_RadOnc
The official account of the Radiation Oncology Department at Memorial Sloan Kettering Cancer Center @MSKCancerCenter #radonc
ID:1164226031273893890
https://www.mskcc.org/departments/radiation-oncology 21-08-2019 17:21:50
1,7K Tweets
4,1K Followers
373 Following
☢️Memorial Sloan Kettering Cancer Center #radonc Dr Fumiko Ladd Chino, MD has been selected for ASCO's Leadership Development Program. This prestigious program is designed to identify, select, and train mid-career-level members to become future leaders at ASCO and in the field of oncology.
🎙️Did you know....
Memorial Sloan Kettering Cancer Center's Vice Chair of Radiation Oncology Clinical Operations Dr Daniel Gomez was on Becker's Hospital Review Healthcare Podcast to discuss his career in #radonc and thoughts on healthcare leadership. 🏥☢️
beckershospitalreview.com/podcasts/podca…
Proud to see Luke del Balzo on the main stage delivering a great talk on the risk of ICH in patients with RCC Brain Mets receiving SRS and VEGFi at ISRSy 2024! Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center
New in JAMA Network Open: In this study, #radiationoncology care provided by fully remote clinicians was safe & feasible, with no serious patient events. High pt satisfaction, substantial cost savings, & decreased environmental consequences were observed.
jamanetwork.com/journals/jaman…
This is brilliant work by John Cuaron. Proud to have helped. This adds to the mounting data from ASCO on the clear utility and safety of telehealth. #radonc #medtwitter Shannon M MacDonald Caleb Trotter Pacific Legal 🗡⚖️
Most insurance denials in radiation oncology were ultimately approved upon appeal; however, radiation technique and/or effectiveness may be compromised by payer-mandated changes, this cohort study of insurer-denied cases finds. ja.ma/3yRljOj Memorial Sloan Kettering Radiation Oncology
New in JAMA Network Open: Most insurance #priorAuthorization denials for #radiation were ultimately reversed on appeal; however, ☢️technique &/or effectiveness may be compromised by payer-mandated changes➡️ delays, ⬇️dose, or less conformal tx delivery.
jamanetwork.com/journals/jaman…
👏🏼Incredible work by John Cuaron and Memorial Sloan Kettering Radiation Oncology showing that remote mgmt of ☢️ radiation cancer care is not only safe and effective, but is associated with:
↑ High patient satisfaction
↓ Lower OOP costs
↓ Smaller carbon footprint
New in JAMA Network Open: In this study, #radiationoncology care provided by fully remote clinicians was safe & feasible, with no serious patient events. High pt satisfaction, substantial cost savings, & decreased environmental consequences were observed.
jamanetwork.com/journals/jaman…
Amazing dinner tonight with some of the ever brilliant Memorial Sloan Kettering Cancer Center #radonc superstar residents. I have had the privilege to work with many of these phenomenal physicians over the past 5 years. It's been a highlight of my Memorial Sloan Kettering Radiation Oncology career. 🤩🙌💫
👏TAKE👏MY👏JOB👏
I have really FLOURISHED here Memorial Sloan Kettering Radiation Oncology. I honestly can say that I would not have been able to accelerate my career to the extent I have as a junior faculty at any other institution.
If you are motivated and driven, this is the perfect place for you.
New in AnnalsSurgOncology: H&N Cutaneous neurotropic #melanoma is prone to local relapse. This trial assessed #radiation therapy to the primary after local excision but closed early. At ~5 yrs, 3 in the observation & 1 in the RT arm had local recurrence.
link.springer.com/article/10.124…
🚨 New in JAMA Network Open — we present findings from the ALIGNMENT trial, a stepped-wedge, cluster RCT testing implementation strategies to promote guideline concordant RT for bone mets across an academic-community partnership. Thanks to Erin Gillespie, MD MPH for leading this work!
☢️🦴New in JAMA Network Open: A stepped-wedge, cluster randomized QI study from the Memorial Sloan Kettering Cancer Center Cancer Alliance to ⬆️use of short-course #radiotherapy for nonspine bone metastases w/in an academic-community partnership.
What worked? What didn't work?
jamanetwork.com/journals/jaman…
Dr Brandon Imber weighs in on the latest IJROBP - The Red Journal #GrayZone to discuss the current controversies for #DLBCL #lymphoma and how to consider bulky disease s/p resection. #lymsm
sciencedirect.com/science/articl…